Table 2.
Medical therapy in heart failure.
| ACEI | ARB | Beta-blocker | MRA | ARNI | SGLT2I | Diuretic | |
|---|---|---|---|---|---|---|---|
| HFrEF | ↑↑ | ↑↑ | ↑↑ | ↑↑ | ↑↑ | ↑↑ | ? |
| HFmrEF | ? | ↑ | ↑ | ↑ | ↑ | ? | ? |
| HFpEF | × | ↑ | × | ↑ | ↑ | ? | ? |
↑↑: Proven cardiovascular benefit.
↑: Potential cardiovascular benefit.
×: No cardiovascular benefit.
?: Uncertain cardiovascular benefit.
ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonist; ARNI, angiotensin receptor—neprilysin inhibitor; SGLT2I, sodium glucose cotransporter 2 inhibitors.